114 related articles for article (PubMed ID: 24005044)
1. Sickle cell anemia: time for personalized prescription of hydroxyurea? Focus on "Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics".
Thornburg CD
Am J Physiol Cell Physiol; 2013 Dec; 305(12):C1209-10. PubMed ID: 24005044
[No Abstract] [Full Text] [Related]
2. Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics.
Walker AL; Lancaster CS; Finkelstein D; Ware RE; Sparreboom A
Am J Physiol Cell Physiol; 2013 Dec; 305(12):C1223-9. PubMed ID: 23986199
[TBL] [Abstract][Full Text] [Related]
3. Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters.
Walker AL; Franke RM; Sparreboom A; Ware RE
Exp Hematol; 2011 Apr; 39(4):446-56. PubMed ID: 21256917
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of hydroxyurea.
Gwilt PR; Tracewell WG
Clin Pharmacokinet; 1998 May; 34(5):347-58. PubMed ID: 9592619
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea: Analytical techniques and quantitative analysis.
Marahatta A; Ware RE
Blood Cells Mol Dis; 2017 Sep; 67():135-142. PubMed ID: 28847416
[TBL] [Abstract][Full Text] [Related]
6. Opportunities for model-based precision dosing in the treatment of sickle cell anemia.
Dong M; Mizuno T; Vinks AA
Blood Cells Mol Dis; 2017 Sep; 67():143-147. PubMed ID: 28807656
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease.
Wiczling P; Liem RI; Panepinto JA; Garg U; Abdel-Rahman SM; Kearns GL; Neville KA
J Clin Pharmacol; 2014 Sep; 54(9):1016-22. PubMed ID: 24729271
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS).
Ware RE; Marahatta A; Ware JL; McElhinney K; Dong M; Vinks AA
J Pediatr; 2020 Jul; 222():236-239. PubMed ID: 32171562
[TBL] [Abstract][Full Text] [Related]
9. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.
Smith NF; Figg WD; Sparreboom A
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):429-45. PubMed ID: 16863454
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile of the anti-sickling hydroxyurea in wild-type and transgenic sickle cell mice.
Iyamu WE; Lian L; Asakura T
Chemotherapy; 2001; 47(4):270-8. PubMed ID: 11399864
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.
Estepp JH; Melloni C; Thornburg CD; Wiczling P; Rogers Z; Rothman JA; Green NS; Liem R; Brandow AM; Crary SE; Howard TH; Morris MH; Lewandowski A; Garg U; Jusko WJ; Neville KA;
J Clin Pharmacol; 2016 Mar; 56(3):298-306. PubMed ID: 26201504
[TBL] [Abstract][Full Text] [Related]
12. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH
Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959
[TBL] [Abstract][Full Text] [Related]
13. Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice.
van de Steeg E; van Esch A; Wagenaar E; Kenworthy KE; Schinkel AH
Clin Cancer Res; 2013 Feb; 19(4):821-32. PubMed ID: 23243220
[TBL] [Abstract][Full Text] [Related]
14. In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters.
Durmus S; Naik J; Buil L; Wagenaar E; van Tellingen O; Schinkel AH
Int J Cancer; 2014 Oct; 135(7):1700-10. PubMed ID: 24554572
[TBL] [Abstract][Full Text] [Related]
15. Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics of R- and S-Warfarin: In Vitro Studies and Mechanistic Evaluation.
Bi YA; Lin J; Mathialagan S; Tylaska L; Callegari E; Rodrigues AD; Varma MVS
Mol Pharm; 2018 Mar; 15(3):1284-1295. PubMed ID: 29433307
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.
Salphati L; Chu X; Chen L; Prasad B; Dallas S; Evers R; Mamaril-Fishman D; Geier EG; Kehler J; Kunta J; Mezler M; Laplanche L; Pang J; Rode A; Soars MG; Unadkat JD; van Waterschoot RA; Yabut J; Schinkel AH; Scheer N
Drug Metab Dispos; 2014 Aug; 42(8):1301-13. PubMed ID: 24855184
[TBL] [Abstract][Full Text] [Related]
17. In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions.
Kindla J; Fromm MF; König J
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):489-500. PubMed ID: 19416085
[TBL] [Abstract][Full Text] [Related]
18. Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes.
Yamaguchi H; Takeuchi T; Okada M; Kobayashi M; Unno M; Abe T; Goto J; Hishinuma T; Shimada M; Mano N
Biol Pharm Bull; 2011; 34(3):389-95. PubMed ID: 21372390
[TBL] [Abstract][Full Text] [Related]
19. Predominant contribution of rat organic anion transporting polypeptide-2 (Oatp2) to hepatic uptake of beta-lactam antibiotics.
Nakakariya M; Shimada T; Irokawa M; Koibuchi H; Iwanaga T; Yabuuchi H; Maeda T; Tamai I
Pharm Res; 2008 Mar; 25(3):578-85. PubMed ID: 17891554
[TBL] [Abstract][Full Text] [Related]
20. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
